Frailty and Cancer Prognosis
View abstract on PubMed
Summary
This summary is machine-generated.Frailty significantly impacts outcomes for older cancer patients, increasing mortality and complications. It also poses risks for cancer survivors, affecting cardiovascular health and overall well-being.
Area Of Science
- Geriatric Oncology
- Clinical Epidemiology
- Cancer Survivorship
Background
- Older adults with cancer represent a growing population with unique health challenges.
- Frailty is an emerging geriatric syndrome associated with adverse health outcomes.
- Understanding frailty's role is crucial for optimizing care in oncology.
Purpose Of The Study
- To review existing evidence on the prognostic significance of frailty in older cancer patients.
- To examine the prognostic implications of frailty in cancer survivors.
Main Methods
- Systematic review of current scientific literature.
- Analysis of studies investigating frailty in diverse oncological settings.
- Exploration of frailty's impact on mortality, complications, and survivorship.
Main Results
- Frailty is consistently linked to increased mortality, postoperative complications, and longer hospital stays in cancer patients.
- Evidence suggests frailty predicts treatment-related toxicity, although this area requires further research.
- In cancer survivors, frailty is a risk factor for cardiovascular disease, diabetes, mortality, cognitive decline, and symptom burden.
Conclusions
- Frailty is a critical prognostic indicator in older cancer patients, influencing survival and treatment outcomes.
- Screening for frailty is valuable for prognosis and guiding treatment decisions in geriatric oncology.
- Frailty assessment is essential for managing long-term health in cancer survivors.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

